SEC Form 4/A · accession 0001140361-16-060918
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Peter C Farrell
Director
Period of report
Apr 4, 2016
Accepted (ET)
Apr 12, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Apr 4, 2016 | M | 20,000 | $25.54 | A | 367,978 | D | |
| ResMed Common StockF3 | Apr 4, 2016 | S | 20,000 | $58.62 | D | 347,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Stock Option PlanF2 | $25.54 | Apr 4, 2016 | M | 20,000 | D | Dec 17, 2010 | Dec 17, 2016 | ResMed Common Stock | 20,000 | 116,085 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vested 1/4 per year on the anniversary of the grant.
- F3This transaction was executed in multiple trades at prices ranging from 58.35 to 58.81. The price reported above represents the weighted average sales price. The reporting person will provide full information about the number of shares and prices at which the transaction was effected, on request, to the SEC staff, the issuer, or the security holder of the issuer.